Update on HIV infection: A report from CROI 2019

R. Bhatia; W. El Atrouni; F. N.U. Shweta; J. Zeuli; S. Rizza; Z. Temesgen

doi:10.1358/dof.2019.44.5.2999434

Update on HIV infection: A report from CROI 2019

R. Bhatia
, W. El Atrouni
, F. N.U. Shweta
, J. Zeuli
, S. Rizza
, Z. Temesgen

Infectious Diseases

Research output: Contribution to journal › Article › peer-review

Abstract

The 2019 Conference on Retroviruses and Opportunistic Infections (CROI 2019) was held March 4-7, 2019, in Seattle, Washington. Important research on all aspects of HIV was presented and discussed. Highlights include introduction of candidate drugs in new classes of antiretrovirals, long-acting antiretrovirals and insights from expansion of pre-exposure prophylaxis in various settings.

Original language	English (US)
Pages (from-to)	385-396
Number of pages	12
Journal	Drugs of the Future
Volume	44
Issue number	5
DOIs	https://doi.org/10.1358/dof.2019.44.5.2999434
State	Published - 2019

Keywords

Fostemsavir
GS-6207
GSK-2838232
Leronlimab
Long-acting antiretroviral drugs
Pre-exposure prophylaxis (PrEP)

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1358/dof.2019.44.5.2999434

Cite this

@article{eb8bd6535d4a42068cc92064455b6870,

title = "Update on HIV infection: A report from CROI 2019",

abstract = "The 2019 Conference on Retroviruses and Opportunistic Infections (CROI 2019) was held March 4-7, 2019, in Seattle, Washington. Important research on all aspects of HIV was presented and discussed. Highlights include introduction of candidate drugs in new classes of antiretrovirals, long-acting antiretrovirals and insights from expansion of pre-exposure prophylaxis in various settings.",

keywords = "Fostemsavir, GS-6207, GSK-2838232, Leronlimab, Long-acting antiretroviral drugs, Pre-exposure prophylaxis (PrEP)",

author = "R. Bhatia and \{El Atrouni\}, W. and Shweta, \{F. N.U.\} and J. Zeuli and S. Rizza and Z. Temesgen",

note = "Publisher Copyright: Copyright {\textcopyright} 2019 Clarivate Analytics",

year = "2019",

doi = "10.1358/dof.2019.44.5.2999434",

language = "English (US)",

volume = "44",

pages = "385--396",

journal = "Drugs of the Future",

issn = "0377-8282",

publisher = "Clarivate",

number = "5",

}

TY - JOUR

T1 - Update on HIV infection

T2 - A report from CROI 2019

AU - Bhatia, R.

AU - El Atrouni, W.

AU - Shweta, F. N.U.

AU - Zeuli, J.

AU - Rizza, S.

AU - Temesgen, Z.

PY - 2019

Y1 - 2019

N2 - The 2019 Conference on Retroviruses and Opportunistic Infections (CROI 2019) was held March 4-7, 2019, in Seattle, Washington. Important research on all aspects of HIV was presented and discussed. Highlights include introduction of candidate drugs in new classes of antiretrovirals, long-acting antiretrovirals and insights from expansion of pre-exposure prophylaxis in various settings.

AB - The 2019 Conference on Retroviruses and Opportunistic Infections (CROI 2019) was held March 4-7, 2019, in Seattle, Washington. Important research on all aspects of HIV was presented and discussed. Highlights include introduction of candidate drugs in new classes of antiretrovirals, long-acting antiretrovirals and insights from expansion of pre-exposure prophylaxis in various settings.

KW - Fostemsavir

KW - GS-6207

KW - GSK-2838232

KW - Leronlimab

KW - Long-acting antiretroviral drugs

KW - Pre-exposure prophylaxis (PrEP)

UR - https://www.scopus.com/pages/publications/85069571538

UR - https://www.scopus.com/pages/publications/85069571538#tab=citedBy

U2 - 10.1358/dof.2019.44.5.2999434

DO - 10.1358/dof.2019.44.5.2999434

M3 - Article

AN - SCOPUS:85069571538

SN - 0377-8282

VL - 44

SP - 385

EP - 396

JO - Drugs of the Future

JF - Drugs of the Future

IS - 5

ER -

Update on HIV infection: A report from CROI 2019

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this